# Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Study · id `cardio:ct-nct05236348` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05236348](<https://clinicaltrials.gov/study/NCT05236348>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05236348

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 225 participants.

## Technical summary

Registry record NCT05236348. Non-randomized; no masking; primary purpose diagnostic. Start 2022-01-11 (actual); primary completion 2025-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 225 participants (planned count; ClinicalTrials.gov record NCT05236348, source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)
- Started: 2022-01-11 (actual) (ClinicalTrials.gov record NCT05236348, source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)
- Primary completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT05236348, source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)
- Completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT05236348, source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT05236348, source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05236348-2024-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation
- Condition: Hypertension
- Condition: Blood Pressure
- Condition: Heart Rate
- Intervention (Device): Aktiia.product-us
- Lead sponsor: Aktiia SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Aktiia SA (`cardio:org-aktiia-sa`)

## Provenance

Content hash: 47297f2c9fbf926bfc48a505fe4dbb3c9367aa0e5284d28d16eb325ae7a8ba8e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
